LobbyingAnnexon Biosciences lobbying by quarter
Annexon Biosciences's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2025; the issues it reports most are Health Issues.
Annexon Biosciences
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $60K | 2 |
| Q3 2025 | $0 | 2 |
| Q4 2025 | $0 | 2 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$60K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES3 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Sidley Austin | $50K | 5 quarters |
| Engel Burns | $10K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| PATRICIA LOUISE DELOATCHE | Health Policy Director, Sen. Orrin Hatch; Chief of Staff, Legislative Director, Legislative Assistant, Rep. Mike Bilirakis | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Sidley Austin | Under $5,000 |
| 04/20for Q1 | Sidley Austin | Under $5,000 |
| 02/19for Q4 2025 | Engel Burns | Under $5,000 |
| 01/20for Q4 2025 | Sidley Austin | Under $5,000 |
| 25/11/20for Q3 2025 | Engel Burns | Under $5,000 |
| 25/10/17for Q3 2025 | Sidley Austin | Under $5,000 |
| 25/07/18for Q2 2025 | Sidley Austin | $50K |
| 25/07/16for Q2 2025 | Engel Burns | $10K |
| 25/07/16for Q2 2025 | Engel Burns | Under $5,000 |
| 25/07/14for Q2 2025 | Sidley Austin | Under $5,000 |